Pharmascience International Ltd
- L01 - Antineoplásicos
- DASATINIB PHARMASCIENCE film-coated tablet 20 mg
- DASATINIB PHARMASCIENCE film-coated tablet 50 mg
- DASATINIB PHARMASCIENCE film-coated tablet 70 mg
- SUNITINIB PHARMASCIENCE capsule, hard 12.5 mg
- SUNITINIB PHARMASCIENCE capsule, hard 25 mg
- SUNITINIB PHARMASCIENCE capsule, hard 37.5 mg
- SUNITINIB PHARMASCIENCE capsule, hard 50 mg
- L02 - Terapia endocrina
- FULVESTRANT PHARMASCIENCE PREFILLED SYRINGE solution for injection 250 mg/5 ml
- L04 - Inmunosupresores
- FINGOLIMOD PHARMASCIENCE capsule, hard 0.5 mg
- LENALIDOMIDE PHARMASCIENCE capsule, hard 10 mg
- LENALIDOMIDE PHARMASCIENCE capsule, hard 15 mg
- LENALIDOMIDE PHARMASCIENCE capsule, hard 25 mg
- LENALIDOMIDE PHARMASCIENCE capsule, hard 5 mg
- V03 - Todos los demás preparados terapéuticos
- DEFERASIROX PHARMASCIENCE film-coated tablet 180 mg
- DEFERASIROX PHARMASCIENCE film-coated tablet 360 mg
- DEFERASIROX PHARMASCIENCE film-coated tablet 90 mg